223 related articles for article (PubMed ID: 25904247)
1. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation.
Wada T; Koyama D; Kikuchi J; Honda H; Furukawa Y
Blood; 2015 Jun; 125(24):3731-46. PubMed ID: 25904247
[TBL] [Abstract][Full Text] [Related]
2. Histone demethylase LSD1 regulates hematopoietic stem cells homeostasis and protects from death by endotoxic shock.
Wang J; Saijo K; Skola D; Jin C; Ma Q; Merkurjev D; Glass CK; Rosenfeld MG
Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E244-E252. PubMed ID: 29263096
[TBL] [Abstract][Full Text] [Related]
3. Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.
Saito S; Kikuchi J; Koyama D; Sato S; Koyama H; Osada N; Kuroda Y; Akahane K; Inukai T; Umehara T; Furukawa Y
Clin Cancer Res; 2019 Mar; 25(5):1601-1611. PubMed ID: 30518632
[TBL] [Abstract][Full Text] [Related]
4. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
McCormack MP; Young LF; Vasudevan S; de Graaf CA; Codrington R; Rabbitts TH; Jane SM; Curtis DJ
Science; 2010 Feb; 327(5967):879-83. PubMed ID: 20093438
[TBL] [Abstract][Full Text] [Related]
5. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18(INK4C)-null reconstituted mice.
Yuan Y; Yu H; Boyer MJ; Song X; Cao S; Shen H; Cheng T
Cancer Res; 2006 Jan; 66(1):343-51. PubMed ID: 16397248
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.
Zhang J; Wang J; Liu Y; Sidik H; Young KH; Lodish HF; Fleming MD
Blood; 2009 Feb; 113(6):1304-14. PubMed ID: 19066392
[TBL] [Abstract][Full Text] [Related]
8. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
[TBL] [Abstract][Full Text] [Related]
9. Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation.
Kerenyi MA; Shao Z; Hsu YJ; Guo G; Luc S; O'Brien K; Fujiwara Y; Peng C; Nguyen M; Orkin SH
Elife; 2013 Jun; 2():e00633. PubMed ID: 23795291
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.
Hino S; Kohrogi K; Nakao M
Cancer Sci; 2016 Sep; 107(9):1187-92. PubMed ID: 27375009
[TBL] [Abstract][Full Text] [Related]
12. Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesis.
Mallaney C; Ostrander EL; Celik H; Kramer AC; Martens A; Kothari A; Koh WK; Haussler E; Iwamori N; Gontarz P; Zhang B; Challen GA
Leukemia; 2019 Oct; 33(10):2506-2521. PubMed ID: 30936419
[TBL] [Abstract][Full Text] [Related]
13.
Wendorff AA; Quinn SA; Rashkovan M; Madubata CJ; Ambesi-Impiombato A; Litzow MR; Tallman MS; Paietta E; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Rabadan R; Van Vlierberghe P; Ferrando AA
Cancer Discov; 2019 Mar; 9(3):436-451. PubMed ID: 30567843
[TBL] [Abstract][Full Text] [Related]
14. Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells.
Chiang MY; Shestova O; Xu L; Aster JC; Pear WS
Blood; 2013 Feb; 121(6):905-17. PubMed ID: 23115273
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic promotion of osteogenic differentiation of human adipose-derived stem cells by the genetic and chemical blockade of histone demethylase LSD1.
Ge W; Liu Y; Chen T; Zhang X; Lv L; Jin C; Jiang Y; Shi L; Zhou Y
Biomaterials; 2014 Jul; 35(23):6015-25. PubMed ID: 24794925
[TBL] [Abstract][Full Text] [Related]
16. Ezh2 loss propagates hypermethylation at T cell differentiation-regulating genes to promote leukemic transformation.
Wang C; Oshima M; Sato D; Matsui H; Kubota S; Aoyama K; Nakajima-Takagi Y; Koide S; Matsubayashi J; Mochizuki-Kashio M; Nakano-Yokomizo T; Bai J; Nagao T; Kanai A; Iwama A; Sashida G
J Clin Invest; 2018 Aug; 128(9):3872-3886. PubMed ID: 30080177
[TBL] [Abstract][Full Text] [Related]
17. Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia.
Cramer SD; Hixon JA; Andrews C; Porter RJ; Rodrigues GOL; Wu X; Back T; Czarra K; Michael H; Cam M; Chen J; Esposito D; Senkevitch E; Negi V; Aplan PD; Li W; Durum SK
Leukemia; 2018 Aug; 32(8):1795-1882. PubMed ID: 29535426
[No Abstract] [Full Text] [Related]
18. The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1.
Carmichael CL; Wang J; Nguyen T; Kolawole O; Benyoucef A; De Mazière C; Milne AR; Samuel S; Gillinder K; Hediyeh-Zadeh S; Vo ANQ; Huang Y; Knezevic K; McInnes WRL; Shields BJ; Mitchell H; Ritchie ME; Lammens T; Lintermans B; Van Vlierberghe P; Wong NC; Haigh K; Thoms JAI; Toulmin E; Curtis DJ; Oxley EP; Dickins RA; Beck D; Perkins A; McCormack MP; Davis MJ; Berx G; Zuber J; Pimanda JE; Kile BT; Goossens S; Haigh JJ
Blood; 2020 Aug; 136(8):957-973. PubMed ID: 32369597
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
Shing DC; Trubia M; Marchesi F; Radaelli E; Belloni E; Tapinassi C; Scanziani E; Mecucci C; Crescenzi B; Lahortiga I; Odero MD; Zardo G; Gruszka A; Minucci S; Di Fiore PP; Pelicci PG
J Clin Invest; 2007 Dec; 117(12):3696-707. PubMed ID: 18037989
[TBL] [Abstract][Full Text] [Related]
20. Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.
Ueda T; Nagamachi A; Takubo K; Yamasaki N; Matsui H; Kanai A; Nakata Y; Ikeda K; Konuma T; Oda H; Wolff L; Honda Z; Wu X; Helin K; Iwama A; Suda T; Inaba T; Honda H
Blood; 2015 May; 125(22):3437-46. PubMed ID: 25872778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
